Tehlirian et al 2022_Suppplementary Material
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/w3dp7mtpm2
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary material for Tehlirian et al 2022 'Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled study'
提供机构：
Sonya Frazier
